ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,819Medicare Part D Prescriptions Filled, Including Refills

Rank: 331 out of 972

$280K Total Retail Price of All Prescriptions

Rank: 580 out of 972

516 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 516 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 516 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 8,180 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
HYDROCHLOROTHIAZIDE 498 466 1 10
LEVOTHYROXINE SODIUM 485 461 2 3
LISINOPRIL 407 398 3 1
HYDROCODONE-ACETAMINOPHEN 374 330 S3 4 6
ATENOLOL 358 348 5 18
SIMVASTATIN 354 329 6 2
METOPROLOL TARTRATE 263 249 7 9
AMLODIPINE BESYLATE 243 229 8 4
PRAVASTATIN SODIUM 211 201 9 20
WARFARIN SODIUM 198 192 10 12
METFORMIN HCL ER 184 179 11 62
ENALAPRIL MALEATE 175 175 12 50
ALENDRONATE SODIUM 171 169 13 27
LOVASTATIN 164 161 14 22
CITALOPRAM HBR 160 153 15 19
AZITHROMYCIN 157 140 16 42
OMEPRAZOLE 140 129 17 5
PREDNISONE 112 102 18 40
ALLOPURINOL 106 96 19 28
FUROSEMIDE 92 90 20 7
ATORVASTATIN CALCIUM 91 83 21 11
GLIMEPIRIDE 84 82 22 34
SPIRONOLACTONE 82 66 23 54
DONEPEZIL HCL 79 79 24 26
POTASSIUM CHLORIDE 79 79 24 13
LOSARTAN POTASSIUM 76 67 26 17
TAMSULOSIN HCL 76 74 26 29
TRIAMTERENE-HCTZ 72 72 28 39
GLIPIZIDE ER 72 70 28 103
DOXAZOSIN MESYLATE 70 70 30 82
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 66 31 32
METFORMIN HCL 65 63 32 8
RANITIDINE HCL 64 54 33 24
OXYCODONE HCL-ACETAMINOPHEN 60 22 S2 34 106
FENOFIBRATE 59 47 35 66
DIGOXIN 56 56 36 52
AMITRIPTYLINE HCL 52 52 R 37 58
PAROXETINE HCL 52 47 37 64
MORPHINE SULFATE ER 51 18 S2 39 142
TRAMADOL HCL 50 47 40 15
FLUTICASONE PROPIONATE 50 44 40 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.